HOME >> BIOLOGY >> NEWS
Residential Dust Control Fails To Reduce Blood Lead Levels In Children

CINCINNATI -- Dust control -- one of the cornerstones of preventing children's exposure to lead in the home -- is ineffective in reducing blood lead levels, according to a Children's Hospital Medical Center of Cincinnati study published in the April edition of Pediatrics.

"Despite parents' best cleaning efforts, they were not able to keep ahead of lead contamination in their homes," says Bruce Lanphear, M.D., M.P.H., a physician in Cincinnati Children's division of general and community pediatrics and the study's main author.

The study involved 275 urban children, beginning when they were 6 months old. Dust control advisors visited about half these families up to eight times over the next 18 months to recommend and encourage cleaning techniques to reduce dust lead levels. The advisors also provided cleaning equipment and supplies. Children's blood lead levels were measured at 6 months, one year, 18 months, and two years of age.

There was no significant difference in children's blood lead levels at any age between those who performed targeted dust control and those who did not. There also were no differences in the percent of children who had elevated blood lead levels

Lead toxicity, defined as a blood lead level of 10 micrograms per deciliter or higher, is estimated to affect one of every 20 children in the United States. Studies have demonstrated harmful and persistent effects of low-level lead exposure on brain function, such as lowered intelligence and diminished school performance.

"Since the harm from lead persists, trying to fix the problem after the child has a high blood lead test is absurd," says Dr. Lanphear. "We need to expand our efforts to screen housing, identify lead hazards and repair them before a child is exposed. Lead poisoning occurs because housing is in substandard condition, not because families don't clean adequately. Federal residential lea
'"/>

Contact: Jim Feuer
feuej0@chmcc.org
513-636-4656
Cincinnati Children's Hospital Medical Center
5-Apr-1999


Page: 1 2

Related biology news :

1. Controlling biomolecules with magnetic tweezers
2. Controlling the internal clock in darkness
3. Controlling body size by regulating the number of cells
4. Controlling cell adhesion: Researchers report first evidence of catch bonds
5. Control of intestinal inflammation by PGE2 and its receptor
6. Control of fat cell development demonstrated using Sangamo BioSciences ZFP technology
7. Controlled nerve growth factor aids brain cell transplant
8. Controlling greenhouse gas carbon dioxide through carbon sequestration two-day symposium, April 2-3
9. New Gene Holds Promise For Controlling Crohns And Other Inflammatory Diseases
10. Researchers Discover Fast Efficient, Controllable Way To Study Molecular Interactions
11. Discovery Of A Molecule That Controls Bile Acids May Lead To New Cholesterol Drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/1/2019)... ... July 30, 2019 , ... Keck Graduate Institute (KGI) ... Rathmann Professor in Bioprocessing and Director of the Amgen Bioprocessing Center, effective July ... industry and possesses more than 25 years of global experience in bioprocessing,” Schuster ...
(Date:7/26/2019)... LOS ANGELES (PRWEB) , ... July 26, 2019 ... ... pleased to announce an exclusive interview with Helius Medical Technologies CEO Phil Deschamps ... or trauma. , Helius Medical Technologies is a neurotech company in ...
(Date:7/23/2019)... ... 22, 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem ... of a person’s own adipose-derived stem cells to treat their osteoarthritis. The first clinical ... in the knee. , This is the first of several planned clinical ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 11, 2019 , ... Veterinary Regenerative ... Inc. (PSC) , has announced that their GMP facility for cell production is ... for manufacturing. This is an important milestone for VetStem as it expands ...
(Date:6/6/2019)... ... June 05, 2019 , ... WCCT Global, Inc ... device industries, announced today that they will be receiving 3 awards at the 2019 ... WCCT received 2 awards in the categories of overall Quality and Compatibility (Access to ...
(Date:5/31/2019)... ... May 29, 2019 , ... ... applications from the USPTO providing proprietary interest to our methodology, processes, and ... DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP rights including our proprietary sleep ...
(Date:5/31/2019)... ... May 30, 2019 , ... Object Pharma, Inc., ... strategic acquisition of Metabiologics, Inc., a globally recognized leader in the production and ... commercialization rights to a full spectrum of botulinum neurotoxins, as well as a ...
Breaking Biology Technology:
Cached News: